Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Characterization of human fibroblasts from cancer patients: loss of fibrin clot retractile activity after 'in vitro' spontaneous transformation,.

Dolfini E, Azzarone B, Pedulla D, Ottaviano E, De Gaetano G, Donati MB, Morasca.

Eur J Cancer. 1976 Oct;12(10):823-5. No abstract available.

PMID:
976290
2.

Fibrin clot retractile activity in normal, established, and tumorigenic human epithelial cells in culture.

Azzarone B, Macieira-Coelho A, Curatolo L, Brouty-Boyé D, Varnier O, Donati MB, Morasca L.

J Natl Cancer Inst. 1983 Nov;71(5):879-85.

PMID:
6580487
3.

Fibrin clot retractile (FCR) activity of fibroblast-like cells from normal individuals and cancer patients.

Curatolo L, Borgia R, Donati MB, Morasca L.

Cell Biol Int Rep. 1982 Jun;6(6):609-18. No abstract available.

PMID:
7105192
4.

Fibrin clot retraction in normal and transformed avian fibroblasts.

Azzarone B, Curatolo C, Carloni G, Doanti MB, Morasca L, Macieira-Coelho A.

J Natl Cancer Inst. 1981 Jul;67(1):89-94.

PMID:
6265684
5.

Impaired spreading of transformed cells on fibrin substrate.

Donati MB, Curatolo L, Amato G, Morasca L.

Cell Biol Int Rep. 1983 Jun;7(6):427-32.

PMID:
6883519
6.

The role of fibroblasts in organization and degradation of a fibrin clot.

Mirshahi M, Azzarone B, Soria J, Mirshahi F, Soria C.

J Lab Clin Med. 1991 Apr;117(4):274-81.

PMID:
2010668
7.

Skin fibroblasts from a patient with Glanzmann's thrombasthenia do not induce fibrin clot retraction.

Donati MB, Balconi G, Remuzzi G, Borgia R, Morasca L, de Gaetano G.

Thromb Res. 1977 Jan;10(1):173-4. No abstract available.

PMID:
850899
8.

Modulation of fibroblast-induced clot retraction by calcium channel blocking drugs and the monoclonal antibody ALB6.

Azzarone B, Krief P, Soria J, Boucheix C.

J Cell Physiol. 1985 Dec;125(3):420-6.

PMID:
3864783
9.

Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells.

Tanoue K, Katagiri Y, Suzuki H.

Pol J Pharmacol. 1996 May-Jun;48(3):341-3.

PMID:
9112674
10.

Fibrin clot retractile activity of mouse fibroblasts during growth and aging.

Curatolo L, Balconi G, Borgia R, Morasca L, Donati MB.

In Vitro. 1980 Sep;16(9):731-7.

PMID:
7409833
11.

Increased retraction of fibrin clots by endothelial cells of infants of diabetic mothers.

Nappi C, Cerbone AM, Papa R, Di Minno G, Cortese A, Farace MS, Turco S, Montemagno U, Mancini M.

Biol Res Pregnancy Perinatol. 1985;6(3):141-2.

PMID:
3834950
12.
13.
14.

Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.

Mendonca MS, Fasching CL, Srivatsan ES, Stanbridge EJ, Redpath JL.

Radiat Res. 1995 Jul;143(1):34-44.

PMID:
7597142
15.

Characterization of transformed cell lines evolving from a normal C3H line.

Curatolo L, Frascotti G, Ubezio P, Mannironi C, Morasca L.

Exp Cell Biol. 1988;56(1-2):20-8.

PMID:
3181596
16.

Relationship between fibrin clot retraction and tumorigenesis in C3H/10T1/2 cells.

Azzarone B, Brouty-Boyé D, Macieira-Coelho A.

Int J Cancer. 1981 Dec;28(6):799-803.

PMID:
7333708
17.

Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3.

Chen YP, O'Toole TE, Leong L, Liu BQ, Diaz-Gonzalez F, Ginsberg MH.

Blood. 1995 Oct 1;86(7):2606-15.

18.

Role of cytoskeletal elements in the retractile activity of human skin fibroblasts.

Azzarone B, Macieira-Coelho A.

Exp Cell Res. 1984 Nov;155(1):299-304.

PMID:
6541590
19.

Further characterization of the defects of skin fibroblasts from cancer patients.

Azzarone B, Macieira-Coelho A.

J Cell Sci. 1987 Feb;87 ( Pt 1):155-62.

20.

[Role of telomerase in chrysotile induced malignant transformation of normal human embryonic lung fibroblasts].

Xu M, Liu BC, Zhang XM, Shi XL, He P, You BR, Kang N.

Zhonghua Yu Fang Yi Xue Za Zhi. 2004 May;38(3):167-71. Chinese.

PMID:
15182483

Supplemental Content

Support Center